Interleukin-1β (rs 1143627 T/C) Gene Polymorphism May Increase the Risk of Developing LDD in Turkish Population

NCT05601739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 94

Last updated 2022-11-01

No results posted yet for this study

Summary

This study aims to show the association between the Interleukin-1β (rs 1143627 T/C) gene polymorphism and the patient's pain level, radiological features, functional disability, and spinal flexibility.

Conditions

Sponsors & Collaborators

  • Yeditepe University

    lead OTHER

Principal Investigators

  • Dilek Ünsal, M.S.c · Yeditepe University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-08
Primary Completion
2019-11-10
Completion
2020-04-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05601739 on ClinicalTrials.gov